You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

4 Results
Drug
Other Name(s): Busulfex® , Myleran®
Jun 2019
Regimen
Cancer Type:
Gynecologic, 
Germ Cell
Intent: Adjuvant
Dec 2021
Guidelines and Advice
Status: In-Review
ID: RR 21-5
Version: n/a
Jan 2019
Guidelines and Advice
Jun 2021